NewsRoom Articles - Page 117 of 615

WednesdayJul 26, 2023 4:20 am

420 with CNW — Ohio Adds IBS to Medical Cannabis Qualifying Conditions List

Regulators in Ohio have added irritable bowel syndrome (IBS) to the state’s medical marijuana list of qualifying conditions. During the recent Ohio State Medical Board meeting, lawmakers made irritable bowel syndrome the 26th qualifying condition for a medical marijuana license in the state. IBS is one of the most common chronic conditions in America, affecting an estimated 25 to 45 million people in the country and costing the U.S. a whopping $1.3 billion in medical costs annually. The chronic condition is characterized by symptoms such as abdominal pain, diarrhea, cramping, gas and bloating, and affects roughly 5% to 10% of…

TuesdayJul 25, 2023 4:20 pm

420 with CNW — Meta to Let Hemp and CBD Firms Advertise on IG, Facebook

CBD and hemp firms recently scored a major win after Facebook’s parent company Meta loosened its hemp and cannabis advertising policies. In a recent notice, Meta announced the changes to its advertising policies and noted that companies in the cannabis space would now be allowed to advertise non-ingestible cannabidiol products under certain limitations. The social media giant also said that CBD-infused products that have 0.3% or less of THC can be promoted on its platforms if those products meet certain conditions. America’s state-level cannabis industry has been incredibly lucrative from its inception, generating billions of dollars in sales and creating…

TuesdayJul 25, 2023 4:20 am

420 with CNW — BJS Report Reveals a 61% Reduction in Marijuana Incarcerations as State-Level Legalization Spreads

A recent report from the Bureau of Justice Statistics (BJS) has revealed significant developments in drug-related incarcerations within the federal prison system. The number of individuals imprisoned for marijuana offenses dropped by a remarkable 61%, surpassing reductions seen in other drug categories between 2013 and 2018. Overall, drug-related incarcerations in federal prisons decreased by 24% during the same timeframe. However, the report highlights that nearly one-half of the Bureau of Prisons' population in 2018 consisted of individuals impacted by the war on drugs. While marijuana cases saw the most substantial decline at 61%, powder and crack cocaine incarcerations also significantly…

MondayJul 24, 2023 4:20 pm

420 with CNW — Michigan Registers a Record-Setting $261M in June Cannabis Sales

June witnessed a remarkable achievement in marijuana sales in Michigan as the figures soared to an unprecedented peak, nearing a staggering $261 million. The lion's share of this impressive total, amounting to $254,153,133, was contributed by adult-use marijuana purchases, while medical cannabis sales reached $6,643,877. This remarkable feat exceeded the previous record set in March by a margin of more than $10 million. According to data from the Michigan Cannabis Regulatory Agency (CRA), the majority of cannabis purchases consisted of flowers, followed closely by vape cartridges and infused edibles. Despite these remarkable sales records, Michigan continues to witness a noteworthy…

MondayJul 24, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Publishes Eighth Peer-Reviewed Article in International Journal of Molecular Science

The article covers the concentration of cannabidiol in hypertensive women and men using the company’s patented DehydraTECH(TM)-processed CBD The global cardiovascular drugs market is expected to grow from $146.51 billion in 2021, reaching $173.48 billion in 2026, growing at a CAGR of 3.1% The article supports Lexaria’s efforts as it pursues IND status from the FDA for DehydraTECH-CBD as a potential treatment for hypertension Company is planning to begin preparations for a clinical trial that could start as early as the fourth quarter Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced that its groundbreaking research…

MondayJul 24, 2023 4:20 am

420 with CNW — States Share Key Data to Facilitate Federal Cannabis Scheduling Review

States with medical cannabis markets have begun sharing data with the Biden administration to aid in the government’s review of marijuana’s federal classification. While more than 30 states may have legalized medical cannabis use over the past two decades, cannabis still remains illegal at the federal level, classified as a Schedule I drug with no medical applications alongside dangerous drugs like heroin, and cocaine. However, the fact that cannabis has several proven medical applications and is already being used by millions of Americans for therapeutic reasons shows that cannabis doesn’t belong in the same class as cocaine or heroin. Efforts…

FridayJul 21, 2023 4:20 pm

420 with CNW — Five Challenges Marijuana Equity Companies Face

Social-equity founders in America’s state-level cannabis industry are facing a myriad of challenges despite enjoying purported industry support. Social equity refers to a set of policies designed to give people who were disproportionately affected by the drug war a leg up in the cannabis industry. These policies are meant to give communities that endured over policing and harsh sentencing for decades due to prohibitionist cannabis laws a chance to benefit from a drug that was once used to persecute them. However, despite the good intentions behind social-equity provisions, founders from communities of color and lower-income communities still struggle to carve…

FridayJul 21, 2023 4:20 am

420 with CNW — Ukraine to End Cannabis Prohibition to Help Manage Mental-Health War Effects

Ukrainian members of parliament (MPs) have unanimously approved a measure to legalize marijuana, aiming to provide relief for war veterans struggling with physical and psychological trauma. The proposed bill, which permits the medical use of cannabis, effortlessly passed its initial reading, garnering support from 268 out of 344 legislators. Prior to becoming law, it must undergo a second reading in parliament and obtain the signature of President Volodymyr Zelensky. The significant backing for medical cannabis marks a notable shift in attitudes toward the substance since Russia's invasion of Ukraine. In 2021, a similar bill faced resounding defeat. Today, cannabis is…

ThursdayJul 20, 2023 4:20 pm

420 with CNW — Data Suggests Celeb-Backed Cannabis Brands Perform Better

Data from the cannabis-focused online publication MJBizDaily has revealed that celebrity-backed cannabis brands are performing better than traditional brands. Cannabis brands with celebrity endorsements take advantage of the hundreds of thousands to millions of fans and massive social media followings of celebrities to create buzz about their products and attract customers. Unlike other industries, players in the cannabis sector are subject to extremely strict marketing and advertising rules that prevent them from marketing their products in most conventional advertising spaces. One of the tactics such companies have adopted to circumvent advertising restrictions is partnering up with various celebrities to endorse…

ThursdayJul 20, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Is Building a Robust and Growing International Patent Portfolio for DehydraTECH(TM) in Support of Commercial Opportunities

Lexaria is a global innovator in drug delivery platforms with an expanding portfolio of patents that currently stands at 34 granted patents and many patents pending worldwide These patents pertain to the company’s method of improving bioavailability and taste as well as the use of DehydraTECH(TM) as a delivery platform for a wide variety of active pharmaceutical ingredients (“APIs”) The company has, since June 2015, simultaneously filed the US utility patent application and an international patent application under the Patent Cooperation Treaty (“PCT”) procedure, both through the USPTO The PCT procedure has made the process of initiating international patent applications…